Page 4 - Functional Class News Today

MORRISVILLE, N.C., May 04, 2023 -- Liquidia Corporation today reported financial results for the first quarter ended March 31, 2023. The Company will host a webcast at 8:30 a.m. ET to discuss the... | May 4, 2023

New agreement supersedes the collaboration agreement entered in 2012GSK retains non-exclusive right to use PRINT for pre-clinical research for inhaled deliveryLiquidia can apply PRINT to any... | April 3, 2023

Treatment with Aficamten Resulted in Significant Improvements in Heart Failure Symptoms and Cardiac Biomarkers in Patients with Non-Obstructive...

Liquidia and Sandoz will collaborate with Mainbridge Health Partners to develop a new infusion pumpLiquidia and Sandoz have also extended the term of their promotion agreement for Treprostinil... | December 5, 2022

Company to host webcast and conference call today at 8:30 a.m. ETMORRISVILLE, N.C., Nov. 08, 2022 -- Liquidia Corporation today reported financial results for the third quarter ended September... | November 8, 2022

Treatment with Aficamten Associated with Significant Improvements in Symptoms and Quality of Life Additional Data Presented in Poster Session Shows...

Five late-breaking presentations at TCT 2022 highlight the impact of Abbott's structural heart devices to repair or replace heart valves and close openings in the heart

Abbott today announced post-approval study results supporting its MitraClip G4 system for treating mitral regurgitation (MR).

/PRNewswire/ -- Abbott (NYSE: ABT) today announced data from five late-breaking presentations showing the benefits of its minimally invasive devices in...

/PRNewswire/ -- Abbott (NYSE: ABT) today announced data from five late-breaking presentations showing the benefits of its minimally invasive devices in...